Hologic GGO 3 LLP, a prominent player in the medical technology industry, is headquartered in Great Britain and operates extensively across Europe and North America. Founded in the early 2000s, the company has established itself as a leader in women's health, specialising in innovative diagnostic and surgical solutions. Hologic's core offerings include advanced imaging systems, molecular diagnostics, and gynaecological surgical products, all designed to enhance patient care and improve clinical outcomes. The company's commitment to research and development has led to significant advancements in breast health and cervical cancer screening, positioning it as a trusted name in the healthcare sector. With a strong market presence and a reputation for quality, Hologic GGO 3 LLP continues to drive innovation, making substantial contributions to women's health and overall medical technology.
How does Hologic GGO 3 LLP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hologic GGO 3 LLP's score of 64 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hologic GGO 3 LLP, headquartered in Great Britain, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The organisation is a current subsidiary of Hologic, Inc., and therefore, any climate commitments or emissions data may be inherited from its parent company. Hologic, Inc. has established various climate initiatives, including targets set through the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Hologic GGO 3 LLP are not detailed in the available information. As a subsidiary, Hologic GGO 3 LLP aligns with the broader climate strategies of Hologic, Inc., which may include commitments to reduce emissions across Scope 1, 2, and 3 categories. The absence of specific data highlights the need for further transparency in reporting emissions and climate commitments at the subsidiary level.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | - | - | - | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
Hologic GGO 3 LLP's Scope 3 emissions, which decreased by 10% last year and decreased by approximately 10% since 2020, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Hologic GGO 3 LLP has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.